Protective epitopes on the fusion protein of respiratory syncytial virus recognized by murine and bovine monoclonal antibodies

References

1. Arbiza J., Taylor G., Lopéz J. A., Furze J., Wyld S., Whyte P., Stott E. J., Wertz G., Sullender W., Trudel M., Melero J. A. 1992; Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus. Journal of General Virology 73:2225–2234
   [Google Scholar]
2. Beeler J. A., Van Wyke Coelingh K. 1989; Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function. Journal of Virology 63:2941–2950
   [Google Scholar]
3. Belshe R. B., Van Voris L. P., Mufson M. A. 1982; Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial. Journal of Infectious Diseases 145:311–319
   [Google Scholar]
4. Bourgeois C., Corvaisier C., Bour J. B., Kohli E., Pothier P. 1991; Use of synthetic peptides to locate neutralizing antigenic domains on the fusion protein of respiratory syncytial virus. Journal of General Virology 72:1051–1058
   [Google Scholar]
5. Collins P. L., Huang Y. T., Wertz G. W. 1984; Nucleotide sequence of the gene encoding the fusion (F) glycoprotein of human respiratory syncytial virus. Proceedings of the National Academy of Sciences, U.S.A. 81:7683–7687
   [Google Scholar]
6. Elango N., Satake M., Coligan J. E., Norrby E., Camargo E., Venkatesan S. 1985; Respiratory syncytial virus fusion glycoprotein: nucleotide sequence of mRNA, identification of cleavage activation site and amino acid sequence of N-terminus of FI subunit. Nucleic Acids Research 13:1559–1573
   [Google Scholar]
7. Fernie B. F., Ford E. C., Gerin J. I. 1981; The development of BALB/c cells persistently infected with respiratory syncytial virus: presence of ribonucleoprotein on the cell surface. Proceedings of the Society for Experimental Biology and Medicine 167:83–86
   [Google Scholar]
8. Fulginiti V. A., Eller J. J., Sieber O. F., Joyner J. W., Minamitani M., Meiklejohn G. 1969; Respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum precipitated respiratory syncytial virus vaccine. American Journal of Epidemiology 89:435–448
   [Google Scholar]
9. Garcia-Barreno B., Palomo C., Penas C., Delgardo T., Perez-Brena P., Melero J. A. 1989; Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins. Journal of Virology 63:925–932
   [Google Scholar]
10. Gilks G. R. 1990 Leukocyte Typing Database IV Oxford: Oxford University Press;
    [Google Scholar]
11. Kennedy H. E., Jones B. V., Tucker E. M., Ford N. J., Clarke S. W., Furze J., Thomas L. H., Stott E. J. 1988; Production and characterization of bovine monoclonal antibodies to respiratory syncytial virus. Journal of General Virology 69:3023–3032
    [Google Scholar]
12. Kim H. W., Arrobio J. G., Brandt C. D., Jeffries B. C., Pyle G., Reid J. L., Chanock R. M., Parrott R. H. 1973; Epidemiology of respiratory syncytial infection in Washington, D. C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. American Journal of Epidemiology 98:216–225
    [Google Scholar]
13. Kimman T. G., Sol J., Westenbrink F., Straver P. J. 1989; A severe outbreak of respiratory tract disease associated with bovine respiratory syncytial virus probably enhanced by vaccination with modified live virus. Veterinary Quarterly 11:250–253
    [Google Scholar]
14. Lerch R. A., Stott E. J., Wertz G. W. 1989; Characterization of bovine respiratory syncytial virus proteins and mRNAs and generation of cDNA clones to the viral mRNAs. Journal of Virology 63:833–840
    [Google Scholar]
15. Lerch R. A., Anderson K., Wertz G. W. 1990; Nucleotide sequence analysis and expression from recombinant vectors demonstrate that the attachment protein G of bovine respiratory syncytial virus is distinct from that of human respiratory syncytial virus. Journal of Virology 64:5559–5569
    [Google Scholar]
16. Lewis F. A., Rae M. L., Lehman N. I., Ferris A. A. 1961; A syncytial virus associated with epidemic disease of the lower respiratory tract in infants and young children. Medical Journal of Australia 48:932–933
    [Google Scholar]
17. Lopez J. A., Penas C., Garcia-Barreno B., Melero J. A., Portela A. M. 1990; Location of a highly conserved neutralizing epitope in the F glycoprotein of human respiratory syncytial virus. Journal of Virology 64:927–930
    [Google Scholar]
18. Olmsted R. A., Elango N., Prince G. A., Murphy B. R., Johnson P. R., Moss B., Collins P. 1986; Expression of the F1 glycoprotein of respiratory syncytial virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proceedings of the National Academy of Sciences, U.S.A. 83:7462–7466
    [Google Scholar]
19. Paradiso P. R., Hu B. T., Armugham R., Hildreth S. 1991 Mapping of a fusion related epitope of the respiratory syncytial virus fusion protein, Vaccine 9:231–237
    [Google Scholar]
20. Scopes G. E., Watt P. J., Lambden P. R. 1990; Identification of a linear epitope on the fusion glycoprotein of respiratory syncytial virus. Journal of General Virology 71:53–59
    [Google Scholar]
21. Stott E. J., Thomas L. H., Collins A. P., Crouch S., Jebbett J., Smith G. S., Luther P. D., Caswell R. 1980; A survey of virus infections of the respiratory tract of cattle and their association with disease. Journal of Hygiene 85:257–270
    [Google Scholar]
22. Stott E. J., Taylor G., Ball L. A., Anderson K., Young K.-Y., King A. M. Q., Wertz G. W. 1987; Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus. Journal of Virology 61:3855–3861
    [Google Scholar]
23. Taketa K., Ichikawa E., Taga H., Hirai H. 1985; Antibody-affinity blotting, a sensitive technique for the detection of α- foetoprotein separated by lectin affinity electrophoresis in agarose gels. Electrophoresis 6:492–497
    [Google Scholar]
24. Taylor G., Stott E. J., Bew M., Fernie B. F., Cote P. J., Collins A. P., Hughes M., Jebbett J. 1984a; Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology 52:137–142
    [Google Scholar]
25. Taylor G., Stott E. J., Hughes M., Collins A. P. 1984b; Respiratory syncytial virus infection in mice. Infection and Immunity 43:649–655
    [Google Scholar]
26. Tempest P. R., Bremner P., Lambert M., Taylor G., Furze J. M., Carr F. J., Harris W. J. 1991; Reshaping a human monoclonal antibody to inhibit human respiratory syncytial virus infection in vivo . Bio I Technology 9:266–271
    [Google Scholar]
27. Trudel M., Nadon F., Seguin C., Payment P., Talbot P. T. 1987a; Respiratory syncytial virus fusion glycoprotein: further characterization of a major epitope involved in virus neutralisation. Canadian Journal of Microbiology 33:933–938
    [Google Scholar]
28. Trudel M., Nadon F., Seguin C., Dionne G., Lacroix M. 1987b; Identification of a synthetic peptide as part of a major neutralization epitope of respiratory syncytial virus. Journal of General Virology 68:2273–2280
    [Google Scholar]
29. Walsh E. E., Schlesinger J. J., Brandriss M. W. 1984; Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies. Infection and Immunity 43:756–758
    [Google Scholar]
30. Walsh E. E., Cote P. J., Fernie B. F., Schlesinger J. J., Brandriss M. W. 1986; Analysis of the respiratory syncytial virus fusion protein using monoclonal and polyclonal antibodies. Journal of General Virology 67:505–513
    [Google Scholar]
31. Zygraich N. 1982; Vaccination against RS virus: a five year experience with Rispoval. In Proceedings of the 12th World Congress on Diseases of Cattle Amsterdam; The Netherlands: vol 1 pp 189–195
    [Google Scholar]